Advertisement
News
Subscribe to MDT Magazine News

Integra LifeSciences 3Q profit rises 14.6 percent

October 28, 2010 5:45 am | by The Associated Press | Comments

Medical device maker Integra LifeSciences Holdings Corp. said Thursday its third-quarter profit grew 14.6 percent, led by an increase in orthopedic sales.The company said its profit rose to $16.5 million, or 55 cents per share, from $14.4 million, or 49 cents per share, during the same period a...

Glaucoma therapy firm Solx takes in $3.7M

October 28, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Solx Inc., the Sudbury maker of a laser treatment for glaucoma, has raised $3.7 million in a new round of equity financing, the company reports in a regulatory filing posted yesterday.

Stryker Corp. to buy Boston Scientific division

October 28, 2010 4:45 am | by The Associated Press | Comments

Stryker Corporation says it will pay up to $1.5 billion to buy the neurovascular division of fellow medical device maker Boston Scientific.The Kalamazoo, Mich., company plans to pay $1.4 billion at the deal's closing and then up to $100 million in milestone payments. The deal is expected to...

Advertisement

Boston Scientific Agrees to Sell Neurovascular Business to Stryker

October 28, 2010 4:32 am | by Boston Scientific | Comments

NATICK, Mass., Oct. 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the execution of a definitive agreement under which Stryker Corporation will acquire Boston Scientific's Neurovascular

TOPICS:

VIDEO From thenewsmarket.com and AstraZeneca: AstraZeneca Announces Third Quarter and Nine Months Results 2010

October 28, 2010 2:33 am | by Bio-Medicine.Org | Comments

NEW YORK, Oct. 28 /- See video from AstraZeneca at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=7c13a65b-0529-4b28-82e0-7ebe8b9d9f42&bhcp=1&alertid=226c94c1-b49b-45a9-b982-615158357500# Anglo-Swedish pharmaceutical company AstraZeneca announced that revenue for...

TOPICS:

Adeona to Hold Annual Shareholder Meeting

October 28, 2010 2:33 am | by Bio-Medicine.Org | Comments

ANN ARBOR, Mich., Oct. 28 /- Adeona Pharmaceuticals, Inc., (AMEX: AEN ) announced today that the Company will hold its Annual Shareholders Meeting on Tuesday, November 2, from 9 a.m. to 10 a.m., at its offices located at 3930 Varsity Drive, Ann Arbor, MI, 48108. During the Annual...

TOPICS:

Exposure to BPA associated with reduced semen quality

October 28, 2010 12:33 am | by EurekAlert | Comments

(GolinHarris International) Increasing urine BPA (Bisphenol-A) level was significantly associated with decreased sperm concentration, decreased total sperm count, decreased sperm vitality and decreased sperm motility, according to a Kaiser Permanente study appearing in the journal...

TOPICS:

Atrenta and CEA-Leti sign a multi-year collaboration agreement

October 28, 2010 12:33 am | by I-Micronews | Comments

Focus will be advanced power reduction and 3D design.

Advertisement

Microfluidics: A thousand captures at a time

October 28, 2010 12:33 am | by I-Micronews | Comments

Patch clamping is a widely used laboratory technique to study ion channels in living cells. It is conventionally performed by pressing the open tip of a glass pipette against the membrane of a cell, applying gentle suction to establish a tight seal and then rupturing the cell membrane to...

Digital MEMS microphones from Wolfson target high-quality audio processing in mobile devices

October 28, 2010 12:33 am | by I-Micronews | Comments

Fabless audio chip company Wolfson Microelectronics plc (LSE: WLF.L) launched its next-generation digital silicon micro-electro-mechanical-systems (MEMS) microphones, the WM7210 and the WM7220. The digital MEMS are manufactured with Wolfson?s CMOS/MEMS membrane design, similar to the...

Cell Therapeutics Third Quarter Net Loss Decreases by 68% in 2010 Compared to 2009

October 28, 2010 12:32 am | by Bio-Medicine.Org | Comments

SEATTLE, Oct. 28 /- Cell Therapeutics, Inc. ("CTI" or the "Company") (Nasdaq and MTA: CTIC) today reported recent accomplishments and financial results for the third quarter ended September 30, 2010. "We have made solid progress in controlling costs with a 52% decrease in net operating...

TOPICS:

Cancer Drug Zeroes In on a Genetic Mistake

October 27, 2010 9:34 pm | by Massachusetts Institute of Technology | Comments

An experimental compound shrank lung-cancer tumors in half of the patients in a recent study.

An Implant Could Ease Balance Problems

October 27, 2010 9:33 pm | by Massachusetts Institute of Technology | Comments

A patient has received the first ear implant to treat a balance disorder; researchers hope it leads to similar devices that are even more complex.

Universal Health posts higher 3Q profit

October 27, 2010 6:45 pm | by The Associated Press | Comments

Hospital operator Universal Health Services Inc. said Wednesday its profit increased nearly 9 percent in the third quarter as revenue edged higher.Universal Health lowered the top end of its projected range for 2010 earnings, sending shares lower in after-hours trading.The company reported net...

Gen-Probe to Webcast Two Upcoming Investor Presentations

October 27, 2010 6:32 pm | by Bio-Medicine.Org | Comments

SAN DIEGO, Oct. 27 /- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at the Oppenheimer 21st Annual Healthcare Conference in New York on November 2, 2010 at 11:25 a.m. Eastern time, and at the Lazard Capital Markets 7th Annual Healthcare Conference in...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading